Company
cTRL Therapeutics
Harnessing the power of cTRLs to unlock the next generation of solid tumor cancer therapies
Also known as CTRL THERAPEUTICS USA, INC.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- CTRL THERAPEUTICS USA, INC.
- ctrl-tx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We are harnessing the power of cTRLs – a rare and potent circulating T cell population found in the blood and naturally equipped to fight cancer – to engineer solid tumor cell therapies.
Funding snapshot
- Total raised
- $16.6MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed2024-10-10
Funding rounds
- Round, 2024
- $9.1M2024-09-19, SEC form D sold, 5 investors
- Seed
- $10M2023-04-10, Company stated
- Round, 2022
- $7.5M2022-10-12, SEC form D sold, 7 investors
Loading relationship preview